Dicot Pharma AB (SE0011178458) — research page
SE · se-cm-kg/SSME/SE0011178458 · as of 2026-11-06
Identity and listing
The issuer is Dicot Pharma AB, listed on First North Sweden under ticker SE0011178458, ISIN SE0011178458, LEI 549300GX132RSE4OV407. Security type, segment, sector and jurisdiction are not on the record. Listing status on the record date is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Dicot Pharma AB | source · 2026-11-06 |
| exchange | First North Sweden | source · 2026-11-06 |
| ticker | SE0011178458 | source · 2026-11-06 |
| ISIN | SE0011178458 | source · 2026-11-06 |
| LEI | 549300GX132RSE4OV407 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 36 filings in the twelve months to 2026-11-06, on 35 filing days. The median gap between filing days is 5.5 days. The latest filing is dated 2026-11-02, 4 days before the record date, and is of type Other information disclosed according to the rules of the Exchange. The exchange median cadence gap is 11.0 days across 325 issuers, the exchange median filings count is 21, and the exchange median latency is 7 days. Sector peer figures are not on the record for this market.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 36 | 5.5 | 4 |
| exchange median: First North Sweden (325 issuers) | 21 | 11 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-02 | Other information disclosed according to the rules of the Exchange | Other information disclosed according to the rules of the Exchange | Nomination Committee appointed for Dicot Pharma AB |
| 2026-10-28 | Interim report (Q1 and Q3) | Interim report (Q1 and Q3) | Dicot Pharma presents interim report Q3 2026 and invites to a webcast |
| 2026-10-26 | Investor News | Investor News | Dicot Pharma receives new patent in Europe for LIB-01 |
| 2026-10-13 | Investor News | Investor News | Dicot Pharma's LIB-01 attracted attention when leading experts presented at SMSNA |
| 2026-10-07 | Investor News | Investor News | Dicot Pharma invites to an investor presentation on October 13 |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record and its location are not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is off: the issuer is listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, with chapter as-of date 2026-11-04.
rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations pages read.
Open research
The record holds 6 openly published research notes: Stockpicker on 2023-10-27 (two notes), Aktiespararna on 2021-10-11, Mangold Insight on 2021-03-26, Mangold Insight on 2020-10-08, and Mangold Insight on 2020-05-29.
| date | publisher | note | kind |
|---|---|---|---|
| 2023-10-27 | Stockpicker | Uppdragsanalys 27 oktober 2023 | issuer-sponsored |
| 2023-10-27 | Stockpicker | Commissioned Research, October 27, 2023 | issuer-sponsored |
| 2021-10-11 | Aktiespararna | Marknad med blockbusterpotential | independent |
| 2021-03-26 | Mangold Insight | Dicot - Mot kliniska studier i högt tempo | issuer-sponsored |
| 2020-10-08 | Mangold Insight | Dicot - Framsteg för Viagrautmanare | issuer-sponsored |
| 2020-05-29 | Mangold Insight | Dicot - Erektion som investering | issuer-sponsored |
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No years are sealed for this issuer, no earliest sealed date is recorded for the market, and the live record start date is not on the record.
Sources
7 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.se-cm-kg.ai/events/SSME/SE0011178458 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- 10.5
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://www.dicotpharma.com/en/investor-relations/analysis/ (open research)
- 10.7
- https://mcp.se-cm-kg.ai/record/SSME/SE0011178458 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0011178458"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:180510ba76c11bfe.